ECSP024341A - Composiciones farmaceuticas - Google Patents

Composiciones farmaceuticas

Info

Publication number
ECSP024341A
ECSP024341A EC2002004341A ECSP024341A ECSP024341A EC SP024341 A ECSP024341 A EC SP024341A EC 2002004341 A EC2002004341 A EC 2002004341A EC SP024341 A ECSP024341 A EC SP024341A EC SP024341 A ECSP024341 A EC SP024341A
Authority
EC
Ecuador
Prior art keywords
pharmaceutical compositions
tablet
production
provides
dosage form
Prior art date
Application number
EC2002004341A
Other languages
English (en)
Inventor
Jurgen Dederichs
Thomas Rigassi
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9924043&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ECSP024341(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of ECSP024341A publication Critical patent/ECSP024341A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Transplantation (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Furan Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La invención proporciona una forma de dosis sólida, por ejemplo, una tableta, que comprende ácido micofenólico o una sal micofenolato y un proceso para su producción
EC2002004341A 2001-10-17 2002-11-19 Composiciones farmaceuticas ECSP024341A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0124953.1A GB0124953D0 (en) 2001-10-17 2001-10-17 Organic Compounds

Publications (1)

Publication Number Publication Date
ECSP024341A true ECSP024341A (es) 2003-12-01

Family

ID=9924043

Family Applications (2)

Application Number Title Priority Date Filing Date
EC2002004342A ECSP024342A (es) 2001-10-17 2002-11-19 Nuevos derivados d e fenilpropargileter
EC2002004341A ECSP024341A (es) 2001-10-17 2002-11-19 Composiciones farmaceuticas

Family Applications Before (1)

Application Number Title Priority Date Filing Date
EC2002004342A ECSP024342A (es) 2001-10-17 2002-11-19 Nuevos derivados d e fenilpropargileter

Country Status (31)

Country Link
US (3) US20050013859A1 (es)
EP (1) EP1438040B2 (es)
JP (2) JP2005508959A (es)
KR (1) KR100671367B1 (es)
CN (1) CN1310640C (es)
AR (2) AR036813A1 (es)
AT (1) ATE374023T1 (es)
AU (1) AU2002338897B2 (es)
BR (1) BR0213355A (es)
CA (1) CA2460574A1 (es)
CO (1) CO5390076A1 (es)
CY (1) CY1107841T1 (es)
DE (1) DE60222687T3 (es)
DK (1) DK1438040T4 (es)
EC (2) ECSP024342A (es)
ES (1) ES2292819T5 (es)
GB (1) GB0124953D0 (es)
HU (1) HU231114B1 (es)
IL (2) IL160968A0 (es)
MX (1) MXPA04003636A (es)
MY (1) MY139206A (es)
NO (1) NO341804B1 (es)
NZ (1) NZ532280A (es)
PE (1) PE20030476A1 (es)
PL (2) PL415001A1 (es)
PT (1) PT1438040E (es)
RU (2) RU2338528C2 (es)
SI (1) SI1438040T2 (es)
TW (1) TWI333861B (es)
WO (1) WO2003032978A1 (es)
ZA (1) ZA200401977B (es)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0124953D0 (en) 2001-10-17 2001-12-05 Novartis Ag Organic Compounds
AR045957A1 (es) * 2003-10-03 2005-11-16 Novartis Ag Composicion farmaceutica y combinacion
EP1699773A2 (en) * 2004-07-20 2006-09-13 Ceva Gyogyszergyar R Szv Nytarsasag Processes for preparation of crystalline mycophenolate sodium
GB0419355D0 (en) * 2004-08-31 2004-09-29 Novartis Ag Organic compounds
US20060235070A1 (en) * 2005-02-08 2006-10-19 Hayden Michael R Compositions and methods for treating vascular, autoimmune, and inflammatory diseases
US20060235009A1 (en) 2005-02-08 2006-10-19 Richard Glickman Treatment of vascular, autoimmune and inflammatory diseases using low dosages of IMPDH inhibitors
CN101272780A (zh) * 2005-09-30 2008-09-24 诺瓦提斯公司 用于自身免疫疾病和移植排斥治疗的dpp iv抑制剂
JP5394746B2 (ja) * 2005-12-21 2014-01-22 ビーエーエスエフ ソシエタス・ヨーロピア 錠剤崩壊剤としての微粒子状架橋ポリビニルピロリドン
US20090023805A1 (en) * 2006-02-13 2009-01-22 Anne Claire Marrast Method of administration
CN102083410B (zh) 2007-06-06 2013-04-17 巴斯夫欧洲公司 用于制备迅速崩解的片剂的药物制剂
CN101707930B (zh) 2007-06-06 2013-10-30 巴斯夫欧洲公司 用于制备快速崩解的片剂的药物配制剂
EP2187872A4 (en) * 2007-08-13 2013-09-18 Panacea Biotec Ltd EXTENDED RELEASE COMPOSITIONS COMPRISING SODIUM MYCOPHENOLATE AND METHODS RELATING THERETO
AU2009220779A1 (en) * 2008-03-05 2009-09-11 Panacea Biotec Limited Modified release pharmaceutical compositions comprising mycophenolate and processes thereof
CN102099029A (zh) * 2008-07-09 2011-06-15 阿斯普瑞瓦国际公司 治疗眼部病症的霉酚酸钠的pH值特定溶液
US20110086102A1 (en) * 2009-10-13 2011-04-14 Teva Pharmaceutical Industries Ltd. Delayed release compositions
EA201270544A1 (ru) * 2009-10-13 2012-09-28 Тева Фармасьютикал Индастриз Лтд. Композиции с отсроченным высвобождением
WO2011051967A2 (en) * 2009-10-23 2011-05-05 Alkem Laboratories Ltd Pharmaceutical compositions comprising mycophenolate and processes for preparing thereof
GB201100786D0 (en) 2011-01-18 2011-03-02 Ems Sa Pharmaceutical compositions of immunosuppressants
CN102793658A (zh) * 2012-08-23 2012-11-28 无锡福祈制药有限公司 一种含有麦考酚酸或麦考酚酸盐的骨架型制剂及其包衣片
CN103845323B (zh) * 2012-11-30 2018-02-02 重庆华邦制药有限公司 麦考酚酸及其盐肠溶制剂和制备方法
WO2014167442A1 (en) 2013-03-26 2014-10-16 Wockhardt Limited Pharmaceutical compositions comprising mycophenolic acid or salts thereof
CN106727403A (zh) * 2017-01-03 2017-05-31 无锡福祈制药有限公司 一种麦考酚钠肠溶片及其制备方法
CA3054817A1 (en) * 2017-03-13 2018-09-20 Okava Pharmaceuticals, Inc. Methods and compositions for delivering mycophenolic acid active agents to non-human mammals
JP7635474B2 (ja) 2018-06-06 2025-02-26 プリスティーヌ・エスアーエス 慢性腎疾患を持つ糖尿病対象を治療する方法
EP3806828A1 (en) * 2018-06-14 2021-04-21 Poxel Film-coated tablet comprising a triazine derivative for use in the treatment of diabetes
RU2723255C2 (ru) * 2018-11-14 2020-06-09 Общество с ограниченной ответственностью "Изварино Фарма" Экструдат с микофенолятом натрия для получения пероральной твердой лекарственной формы
AU2021424131A1 (en) * 2021-01-28 2023-07-27 Priothera Limited Methods of treatment with s1p receptor modulators
KR20230136603A (ko) * 2021-01-28 2023-09-26 프리오테라 에스에이에스 S1p 수용체 조정제를 사용한 치료 방법
WO2022250977A1 (en) * 2021-05-26 2022-12-01 The Texas A&M University System Biodegradable mucoadhesive pharmaceutical formulations and methods thereof
CN117442580B (zh) * 2023-12-21 2024-04-05 泊诺(天津)创新医药研究有限公司 一种高生物利用度麦考酚钠肠溶片及其制备方法

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1157099A (en) * 1966-09-27 1969-07-02 Ici Ltd Fermentation Process
GB1157100A (en) † 1966-09-27 1969-07-02 Ici Ltd Pharmaceutical Compositions
GB1203328A (en) * 1968-06-04 1970-08-26 Ici Ltd Pharmaceutical compositions
US3705946A (en) * 1971-05-25 1972-12-12 Lilly Co Eli Method of treating hyperuricemia
US3880995A (en) * 1973-05-14 1975-04-29 Lilly Co Eli Treatment of arthritis with mycophenolic acid and derivatives
JPS56127093A (en) * 1980-03-10 1981-10-05 Ajinomoto Co Inc Preparation of mycophenolic acid
US4959387A (en) * 1986-01-23 1990-09-25 Syntex (U.S.A.) Inc. Mycophenolic acid derivatives in the treatment of rheumatoid arthritis
US4725622A (en) * 1986-01-23 1988-02-16 Syntex (U.S.A.) Inc. Mycophenolic acid derivatives in the treatment of rheumatoid arthritis
US5177072A (en) * 1987-01-30 1993-01-05 Syntex (U.S.A.) Inc. Treatment of autoimmune inflammatory, and psoriatic diseases with heterocyclic aminoalkyl esters of mycophenolic acid and derivatives
US4748173A (en) * 1987-01-30 1988-05-31 Syntex (U.S.A.) Inc. Heterocyclic aminoalkyl esters of mycophenolic acid and derivatives thereof and pharmaceutical compositions
US4753935A (en) * 1987-01-30 1988-06-28 Syntex (U.S.A.) Inc. Morpholinoethylesters of mycophenolic acid and pharmaceutical compositions
JPH08503487A (ja) * 1992-11-24 1996-04-16 シンテックス（ユー・エス・エイ）・インコーポレイテッド 狭窄症を抑止するためのミコフェノール酸、ミコフェノール酸モフェチルまたはそれらの誘導体の使用
WO1994012184A1 (en) * 1992-11-24 1994-06-09 Syntex (U.S.A.) Inc. Use of mycophenolic acid, mycophenolate mofetil or derivate thereof to inhibit stenosis
US5651983A (en) * 1993-02-26 1997-07-29 The Procter & Gamble Company Bisacodyl dosage form for colonic delivery
PL176846B1 (pl) * 1993-02-26 1999-08-31 Procter & Gamble Kompozycja farmaceutyczna w jednostkowej postaci dawkowania do doustnego podawania bisakodylu
US5656290A (en) * 1993-02-26 1997-08-12 The Procter & Gamble Company Bisacodyl dosage form with multiple enteric polymer coatings for colonic delivery
US5843479A (en) * 1993-02-26 1998-12-01 The Procter & Gamble Company Bisacodyl dosage form with multiple enteric polymer coatings for colonic delivery
US5455045A (en) * 1993-05-13 1995-10-03 Syntex (U.S.A.) Inc. High dose formulations
UA39962C2 (uk) * 1993-10-01 2001-07-16 Сінтекс ( С.Ш.А. ) Інк. Фармацевтична композиція, яка містить мофетил мікофеноляту, для орального введення ( варіанти ) та спосіб її одержання ( варіанти )
US5514663A (en) * 1993-10-19 1996-05-07 The Procter & Gamble Company Senna dosage form
EP0724441A1 (en) * 1993-10-19 1996-08-07 The Procter & Gamble Company Picosulphate dosage form
US5482718A (en) * 1994-03-23 1996-01-09 Hoffmann-La Roche Inc. Colon-targeted delivery system
US5686106A (en) * 1995-05-17 1997-11-11 The Procter & Gamble Company Pharmaceutical dosage form for colonic delivery
ID18663A (id) * 1996-04-12 1998-04-30 Novartis Ag Komposisi farmasi berlapis enterik
ATE474590T1 (de) * 1999-05-10 2010-08-15 Paolo Brenner Kombination von immunsuppressiven substanzen zur behandlung oder vorbeugung von transplantat abstossungen
HUP9903226A2 (en) * 1999-09-23 2002-08-28 Gyogyszerki Process for producing mycophenolic acid and derivatives thereof
JP2003525052A (ja) * 2000-02-29 2003-08-26 バイオコン・インディア・リミテッド マイコフェノール酸の製造および精製
GB0124953D0 (en) 2001-10-17 2001-12-05 Novartis Ag Organic Compounds
GB0301259D0 (en) 2003-01-20 2003-02-19 Novartis Ag Organic compounds

Also Published As

Publication number Publication date
JP2009137996A (ja) 2009-06-25
RU2381026C2 (ru) 2010-02-10
CA2460574A1 (en) 2003-04-24
NZ532280A (en) 2007-05-31
TWI333861B (en) 2010-12-01
DE60222687D1 (de) 2007-11-08
HU231114B1 (hu) 2020-09-28
EP1438040B2 (en) 2019-10-16
PT1438040E (pt) 2008-01-02
ES2292819T5 (es) 2020-05-29
KR20050037409A (ko) 2005-04-21
NO20041785L (no) 2004-05-03
PL415001A1 (pl) 2016-02-29
US20120237601A1 (en) 2012-09-20
RU2338528C2 (ru) 2008-11-20
MY139206A (en) 2009-08-28
EP1438040B1 (en) 2007-09-26
PL367738A1 (en) 2005-03-07
PE20030476A1 (es) 2003-07-30
DK1438040T4 (da) 2020-01-27
HUP0600451A2 (en) 2006-09-28
ES2292819T3 (es) 2008-03-16
IL160968A0 (en) 2004-08-31
BR0213355A (pt) 2006-05-23
US20050013859A1 (en) 2005-01-20
WO2003032978A1 (en) 2003-04-24
KR100671367B1 (ko) 2007-01-19
RU2007130786A (ru) 2009-02-20
RU2004115332A (ru) 2005-04-20
US20100210717A1 (en) 2010-08-19
ATE374023T1 (de) 2007-10-15
ECSP024342A (es) 2003-03-10
NO341804B1 (no) 2018-01-22
HK1067861A1 (en) 2005-04-22
CN1310640C (zh) 2007-04-18
EP1438040A1 (en) 2004-07-21
ZA200401977B (en) 2006-05-31
AR036813A1 (es) 2004-10-06
AU2002338897B2 (en) 2006-10-19
IL160968A (en) 2016-04-21
CY1107841T1 (el) 2013-06-19
AR085778A2 (es) 2013-10-30
PL234541B1 (pl) 2020-03-31
CO5390076A1 (es) 2004-04-30
DE60222687T3 (de) 2020-03-05
DK1438040T3 (da) 2008-02-04
MXPA04003636A (es) 2004-07-27
GB0124953D0 (en) 2001-12-05
JP2005508959A (ja) 2005-04-07
SI1438040T2 (sl) 2020-02-28
SI1438040T1 (sl) 2008-04-30
CN1564684A (zh) 2005-01-12
DE60222687T2 (de) 2008-07-17

Similar Documents

Publication Publication Date Title
ECSP024341A (es) Composiciones farmaceuticas
CY1122777T1 (el) Στερεη φαρμακευτικη δοσολογικη φαρμακοτεχνικη μορφη που περιεχει λοπιναβιρη
AR033711A1 (es) Composiciones farmaceuticas
MA26937A1 (fr) Nouvelle composition pharmaceutique.
UY30712A1 (es) Nuevos derivados de 1, 4-benzotiepina-1, 1-dioxido sustituidos con fluor, método para su preparacion, productos farmacéuticos que comprenden estos compuestos y su uso.
ECSP077999A (es) Formulaciones de una sal de bupropion de liberación modificada
AP2003002916A0 (en) HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis.
CO5011053A1 (es) Procedimiento para la produccion de una forma de dosificacion solida que contiene carvedilol e hidroclorotiazida y formas farmaceuticas obtenidas por dicho procedimiento
PT1414816E (pt) Polimorfo estavel da flibanserina, processo tecnico para a sua preparacao e sua utilizacao na preparacao de medicamentos
ATE291908T1 (de) Ibuprofen-wirkstoffzubereitung
MXPA03001425A (es) Compuestos farmaceuticos.
EA200400455A1 (ru) Способ приготовления быстрорастворимой дозировочной формы
ATE367152T1 (de) Herstellungsverfahren für niedrig dosierte pharmazeutische zusammensetzung
BR0311347A (pt) Alcanóis bis-aromáticos
CL2004001421A1 (es) Composicion farmaceutica que comprende un compuesto derivado de 1,4-dipiperidin-4-il-piperazina; y su uso para la prevencion y/o tratamiento del dolor.
MX2021010338A (es) Composicion farmaceutica que contiene acetominofeno e ibuprofeno.
PL377706A1 (pl) Kompozycja farmaceutyczna zawierająca kwas alendronowy, jego sole lub estry oraz sposób jej otrzymywania
BR0101437A (pt) Método para preparar um ciclopropeno
DK1250125T3 (da) Farmaceutiske præparater, som indeholder terbinafin
BR0004645B1 (pt) embalagem, particularmente para o acondicionamento de produtos industriais.
ECSP045053A (es) Composiciones farmaceuticas que comprenden acido micofenolico o sal de micofenolato
PT1001942E (pt) Poli-hidroxibutilpirazinas sua preparacao e medicamentos que as contem
ZA200205598B (en) Benzenesulphonamide compounds, a process for their preparation and pharmaceutical compositions containing them.
NL1023797A1 (nl) Farmaceutische doseringsvorm die zwangerschapsvriendelijke onderscheidingstekens draagt.
BRPI0410638A (pt) derivados de azitromicina